<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="5.3.1" xmlns="http://www.crossref.org/schema/5.3.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xsi:schemaLocation="http://www.crossref.org/schema/5.3.1 http://www.crossref.org/schema/deposit/crossref5.3.1.xsd">
 <head>
  <doi_batch_id>aspg-41-4502-1792223338</doi_batch_id>
  <timestamp>20261017074858</timestamp>
  <depositor>
   <depositor_name>American Scientific Publishing Group</depositor_name>
   <email_address>admin@americaspg.com</email_address>
  </depositor>
  <registrant>American Scientific Publishing Group</registrant>
 </head>
 <body>
  <journal>
   <journal_metadata language="en">
    <full_title>Metaheuristic Optimization Review</full_title>
    <abbrev_title>MOR</abbrev_title>
    <issn media_type="electronic">3066-280X</issn>
   </journal_metadata>
   <journal_issue>
    <publication_date media_type="online">
     <year>2026</year>
    </publication_date>
    <journal_volume>
     <volume>7</volume>
    </journal_volume>
    <issue>2</issue>
   </journal_issue>
   <journal_article publication_type="full_text">
    <titles>
     <title>A Review of Artificial Intelligence-Based Diabetes Prediction Using Machine Learning, Deep Learning, and Optimizer-Assisted Decision Support</title>
    </titles>
    <contributors>
     <person_name sequence="first" contributor_role="author">
      <given_name>Ancy</given_name>
      <surname>Cheriyan</surname>
      <affiliations>
       <institution>
        <institution_name>School of Artificial Intelligence, Bahrain Polytechnic ,PO Box 33349, Isa Town, Bahrain</institution_name>
       </institution>
      </affiliations>
     </person_name>
    </contributors>
    <jats:abstract>
     <jats:p>Diabetes prediction has become an important direction in clinical artificial intelligence because early identification of high-risk individuals can support preventive intervention, personalized monitoring, and improved long-term healthcare outcomes. This review examines recent machine learning, deep learning, and optimizer-assisted methodologies for diabetes prediction and related diagnostic decision support. It discusses how clinical variables, physiological measurements, biomedical signals, retinal images, population-specific attributes, and healthcare monitoring data can be transformed into predictive evidence through preprocessing, feature engineering, feature selection, model training, hyperparameter optimization, and risk interpretation. The review also emphasizes major methodological concerns, including class imbalance, model robustness, interpretability, subgroup variation, complication-oriented prediction, and deployment within connected healthcare environments. Overall, the reviewed literature indicates that effective diabetes prediction should be developed as an integrated clinical decision-support pipeline rather than as a single classifier comparison, with careful attention to data quality, feature relevance, model transparency, and practical healthcare usability.</jats:p>
    </jats:abstract>
    <publication_date media_type="online">
     <year>2026</year>
    </publication_date>
    <pages>
     <first_page>P. 01</first_page>
     <last_page>12</last_page>
    </pages>
    <publisher_item>
     <item_number item_number_type="article-number">4502</item_number>
    </publisher_item>
    <ai:program name="AccessIndicators">
     <ai:license_ref applies_to="vor">https://creativecommons.org/licenses/by/4.0/</ai:license_ref>
    </ai:program>
    <doi_data>
     <doi>10.54216/MOR.070201</doi>
     <resource>https://americaspg.com/journal/41/article/4502</resource>
     <collection property="text-mining">
      <item>
       <resource mime_type="application/pdf">https://americaspg.com/storage/articles/manuscripts/01M2K9BY4JNBGWVT25PNTYEW99.pdf</resource>
      </item>
     </collection>
    </doi_data>
   </journal_article>
  </journal>
 </body>
</doi_batch>
